Crux Wealth Advisors’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-19,194
Closed -$925K 200
2026
Q1
$925K Buy
19,194
+303
+2% +$14.1K 0.35% 81
2025
Q4
$915K Sell
18,891
-126
-0.7% -$6.25K 0.34% 84
2025
Q3
$898K Buy
19,017
+1,193
+7% +$57.6K 0.36% 78
2025
Q2
$861K Buy
17,824
+6,694
+60% +$342K 0.37% 76
2025
Q1
$617K Buy
11,130
+4,734
+74% +$256K 0.32% 91
2024
Q4
$308K Buy
+6,396
New +$325K 0.17% 126

Other funds holding SNY

Crux Wealth Advisors's SNY Position: Q2 2026 in Review

Crux Wealth Advisors sold out of Sanofi (SNY) in Q2 2026, closing a stake of 19,194 shares — an estimated $925K sold.

Crux Wealth Advisors first reported a position in SNY in Q4 2024 and held it in 6 quarters. The position peaked at $925K in Q1 2026. 136 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Crux Wealth Advisors reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Crux Wealth Advisors sold 19,194 Sanofi shares in Q2 2026, an estimated $925K.
  • Crux Wealth Advisors first reported a position in Sanofi in Q4 2024 and held it in 6 quarters.
  • Crux Wealth Advisors's Sanofi position peaked at $925K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Crux Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.